Iovance Biotherapeutics Ownership 2024 | Who Owns Iovance Biotherapeutics Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

9.08%

Insider Ownership

0.50%

Retail Ownership

90.42%

Institutional Holders

121.00

Iovance Biotherapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	9.75%	0.00%	25,950,644	1,035,344	4.16%	208,124,165	Jun 30, 2024
PERCEPTIVE ADVISORS LLC	9.74%	4.94%	25,933,142	6,660,151	34.56%	207,983,798	Jun 30, 2024
MHR FUND MANAGEMENT LLC	9.01%	23.45%	23,997,103	-	-	192,456,766	Jun 30, 2024
BLACKROCK INC.	7.97%	0.00%	21,225,119	1,295,417	6.50%	170,225,456	Jun 30, 2024
STATE STREET CORP	4.74%	0.00%	12,625,177	2,222,458	21.36%	101,253,920,000	Jun 30, 2024
AVORO CAPITAL ADVISORS LLC	4.39%	1.25%	11,700,000	-	-	93,834,000	Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.	2.84%	5.34%	7,548,000	4,043,000	115.35%	60,534,960	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	2.17%	0.00%	5,786,532	279,915	5.08%	46,416,921	Jun 30, 2024
ARTISAN PARTNERS LIMITED PARTNERSHIP	1.92%	0.06%	5,111,409	-26,813	-0.52%	40,993,500	Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.	1.71%	0.06%	4,540,560	3,339,696	278.11%	36,415,291	Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC	1.55%	1.27%	4,132,000	2,731,688	195.08%	33,138,640	Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/	1.31%	0.00%	3,482,402	-1,785,462	-33.89%	27,930,000	Jun 30, 2024
JPMORGAN CHASE & CO	1.29%	0.00%	3,438,232	-947,462	-21.60%	27,574,620	Jun 30, 2024
MORGAN STANLEY	1.06%	0.00%	2,822,863	131,842	4.90%	22,639,362	Jun 30, 2024
HOOD RIVER CAPITAL MANAGEMENT LLC	1.03%	0.45%	2,732,427	108,189	4.12%	21,914,065	Jun 30, 2024
GOLDMAN SACHS GROUP INC	0.98%	0.00%	2,621,784	-1,160,779	-30.69%	21,026,708	Jun 30, 2024
PRINCIPAL FINANCIAL GROUP INC	0.95%	0.01%	2,536,243	530,338	26.44%	20,340,588,000	Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC	0.94%	0.07%	2,491,659	-1,002,525	-28.69%	19,983,105	Jun 30, 2024
BIOIMPACT CAPITAL LLC	0.89%	2.95%	2,366,714	166,714	7.58%	18,981,046	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.85%	0.00%	2,265,555	-605,943	-21.10%	18,169,623	Jun 30, 2024

Iovance Biotherapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 9.75% of the company's total share outstanding, currently valued at $208.12M. The top 10 institutional shareholders own together 54.25% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MHR FUND MANAGEMENT LLC	9.01%	23.45%	23,997,103	-	-	192,456,766	Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.	2.84%	5.34%	7,548,000	4,043,000	115.35%	60,534,960	Jun 30, 2024
PERCEPTIVE ADVISORS LLC	9.74%	4.94%	25,933,142	6,660,151	34.56%	207,983,798	Jun 30, 2024
BIOIMPACT CAPITAL LLC	0.89%	2.95%	2,366,714	166,714	7.58%	18,981,046	Jun 30, 2024
PARAMETRICA MANAGEMENT LTD	0.10%	2.77%	261,090	129,500	98.41%	2,093,942	Jun 30, 2024
	0.30%	2.54%	794,700	794,700	100.00%	6,373,494	Jun 30, 2024
PALO ALTO INVESTORS LP	0.80%	1.97%	2,116,403	3,592	0.17%	16,973,552	Jun 30, 2024
CM MANAGEMENT, LLC	0.09%	1.84%	250,000	-	-	2,005,000	Jun 30, 2024
OPALEYE MANAGEMENT INC.	0.34%	1.64%	897,000	-	-	7,193,940	Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC	1.55%	1.27%	4,132,000	2,731,688	195.08%	33,138,640	Jun 30, 2024
AVORO CAPITAL ADVISORS LLC	4.39%	1.25%	11,700,000	-	-	93,834,000	Jun 30, 2024
683 CAPITAL MANAGEMENT, LLC	0.56%	0.91%	1,500,000	275,000	22.45%	12,030,000	Jun 30, 2024
RICE HALL JAMES & ASSOCIATES, LLC	0.61%	0.79%	1,636,025	-77,800	-4.54%	13,120,921	Jun 30, 2024
RHENMAN & PARTNERS ASSET MANAGEMENT AB	0.35%	0.71%	920,000	-35,000	-3.66%	7,378,400	Jun 30, 2024
QVT FINANCIAL LP	0.25%	0.51%	678,564	-	-	5,442,083	Jun 30, 2024
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC	0.58%	0.48%	1,555,408	-1,410,579	-47.56%	12,474,372	Jun 30, 2024
HOOD RIVER CAPITAL MANAGEMENT LLC	1.03%	0.45%	2,732,427	108,189	4.12%	21,914,065	Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC	0.19%	0.41%	500,000	-	-	4,010,000	Jun 30, 2024
BRAIDWELL LP	0.55%	0.37%	1,466,610	806,588	122.21%	11,762,212	Jun 30, 2024
NEO IVY CAPITAL MANAGEMENT	0.08%	0.33%	212,648	212,648	100.00%	1,705,000	Jun 30, 2024

The largest Iovance Biotherapeutics shareholder by % of total assets is MHR FUND MANAGEMENT LLC. The company owns 24.00M shares of Iovance Biotherapeutics (IOVA), representing 23.45% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PERCEPTIVE ADVISORS LLC	9.74%	4.94%	25,933,142	6,660,151	34.56%	207,983,798	Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.	2.84%	5.34%	7,548,000	4,043,000	115.35%	60,534,960	Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.	1.71%	0.06%	4,540,560	3,339,696	278.11%	36,415,291	Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC	1.55%	1.27%	4,132,000	2,731,688	195.08%	33,138,640	Jun 30, 2024
STATE STREET CORP	4.74%	0.00%	12,625,177	2,222,458	21.36%	101,253,920,000	Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC	0.75%	0.00%	1,994,500	1,814,650	1008.98%	15,995,888	Jun 30, 2024
MARSHALL WACE, LLP	0.61%	0.02%	1,612,055	1,612,055	100.00%	12,928,681	Jun 30, 2024
EAGLE ASSET MANAGEMENT INC	0.73%	0.08%	1,937,709	1,386,691	251.66%	15,617,934	Jun 30, 2024
BLACKROCK INC.	7.97%	0.00%	21,225,119	1,295,417	6.50%	170,225,456	Jun 30, 2024
VANGUARD GROUP INC	9.75%	0.00%	25,950,644	1,035,344	4.16%	208,124,165	Jun 30, 2024
ARTAL GROUP S.A.	0.38%	0.21%	1,011,500	1,011,500	100.00%	8,112,230	Jun 30, 2024
NORGES BANK	0.35%	0.00%	942,983	942,983	100.00%	7,562,724	Jun 30, 2024
BRAIDWELL LP	0.55%	0.37%	1,466,610	806,588	122.21%	11,762,212	Jun 30, 2024
	0.30%	2.54%	794,700	794,700	100.00%	6,373,494	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.29%	0.01%	774,783	774,783	100.00%	6,213,760	Jun 30, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.	0.77%	0.01%	2,050,500	737,161	56.13%	16,446,000	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.81%	0.00%	2,167,225	634,921	41.44%	17,381,146	Jun 30, 2024
PRINCIPAL FINANCIAL GROUP INC	0.95%	0.01%	2,536,243	530,338	26.44%	20,340,588,000	Jun 30, 2024
SG AMERICAS SECURITIES, LLC	0.19%	0.02%	498,390	445,172	836.51%	3,997,000	Jun 30, 2024
SCHRODER INVESTMENT MANAGEMENT GROUP	0.29%	0.01%	769,160	438,377	132.53%	6,168,663	Jun 30, 2024

As of Jun 30 2024, Iovance Biotherapeutics's largest institutional buyer is PERCEPTIVE ADVISORS LLC. The company purchased 6.66M stocks of IOVA, valued at $207.98M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PICTET ASSET MANAGEMENT HOLDING SA	0.35%	0.01%	920,077	-2,330,477	-71.69%	7,379,018	Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/	1.31%	0.00%	3,482,402	-1,785,462	-33.89%	27,930,000	Jun 30, 2024
D. E. SHAW & CO., INC.	0.25%	0.00%	655,830	-1,696,336	-72.12%	5,259,757	Jun 30, 2024
WOODLINE PARTNERS LP	-	-	-	-1,482,859	-100.00%	-	Jun 30, 2024
MILLENNIUM MANAGEMENT LLC	0.06%	0.00%	166,149	-1,450,712	-89.72%	1,332,515	Jun 30, 2024
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC	0.58%	0.48%	1,555,408	-1,410,579	-47.56%	12,474,372	Jun 30, 2024
GOLDMAN SACHS GROUP INC	0.98%	0.00%	2,621,784	-1,160,779	-30.69%	21,026,708	Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC	0.94%	0.07%	2,491,659	-1,002,525	-28.69%	19,983,105	Jun 30, 2024
JPMORGAN CHASE & CO	1.29%	0.00%	3,438,232	-947,462	-21.60%	27,574,620	Jun 30, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC	-	-	-	-642,761	-100.00%	-	Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP	0.85%	0.00%	2,265,555	-605,943	-21.10%	18,169,623	Jun 30, 2024
CANDRIAM S.C.A.	0.19%	0.02%	500,033	-559,109	-52.79%	4,010,078	Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC	0.50%	0.00%	1,328,117	-326,555	-19.74%	10,651,498	Jun 30, 2024
NOMURA ASSET MANAGEMENT CO LTD	-	-	-	-278,135	-100.00%	-	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	-	-	-	-244,447	-100.00%	-	Jun 30, 2024
HRT FINANCIAL LP	0.03%	0.00%	70,967	-225,207	-76.04%	569,000	Jun 30, 2024
MOODY ALDRICH PARTNERS LLC	-	-	-	-224,831	-100.00%	-	Jun 30, 2024
TD ASSET MANAGEMENT INC	0.11%	0.00%	284,878	-220,400	-43.62%	2,284,722	Jun 30, 2024
EAM INVESTORS, LLC	-	-	-	-213,336	-100.00%	-	Jun 30, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP	0.01%	0.00%	23,771	-209,559	-89.81%	190,643	Jun 30, 2024

As of Jun 30 2024, Iovance Biotherapeutics's biggest institutional seller is PICTET ASSET MANAGEMENT HOLDING SA. The company sold -2.33M shares of IOVA, valued at $7.38M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MARSHALL WACE, LLP	0.61%	0.02%	1,612,055	1,612,055	100.00%	12,928,681	Jun 30, 2024
ARTAL GROUP S.A.	0.38%	0.21%	1,011,500	1,011,500	100.00%	8,112,230	Jun 30, 2024
NORGES BANK	0.35%	0.00%	942,983	942,983	100.00%	7,562,724	Jun 30, 2024
	0.30%	2.54%	794,700	794,700	100.00%	6,373,494	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.29%	0.01%	774,783	774,783	100.00%	6,213,760	Jun 30, 2024
CAPITAL FUND MANAGEMENT S.A.	0.14%	0.01%	383,260	383,260	100.00%	3,073,745	Jun 30, 2024
VESTAL POINT CAPITAL, LP	0.11%	0.18%	300,000	300,000	100.00%	2,406,000	Jun 30, 2024
SQUAREPOINT OPS LLC	0.10%	0.00%	257,543	257,543	100.00%	2,065,495	Jun 30, 2024
NEO IVY CAPITAL MANAGEMENT	0.08%	0.33%	212,648	212,648	100.00%	1,705,000	Jun 30, 2024
QUANTITATIVE INVESTMENT MANAGEMENT, LLC	0.07%	0.16%	187,508	187,508	100.00%	1,503,000	Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC	0.06%	0.14%	150,000	150,000	100.00%	1,203,000	Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.	0.05%	0.00%	145,760	145,760	100.00%	1,168,742	Jun 30, 2024
COREBRIDGE FINANCIAL, INC.	0.05%	0.01%	136,213	136,213	100.00%	1,092,428	Jun 30, 2024
ABRDN PLC	0.05%	0.00%	131,800	131,800	100.00%	1,057,036	Jun 30, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC	0.04%	0.08%	112,277	112,277	100.00%	900,462	Jun 30, 2024
EDGESTREAM PARTNERS, L.P.	0.04%	0.04%	99,605	99,605	100.00%	798,832	Jun 30, 2024
VIRTU FINANCIAL LLC	0.04%	0.05%	94,099	94,099	100.00%	755,000	Jun 30, 2024
MAGNETAR FINANCIAL LLC	0.03%	0.01%	82,363	82,363	100.00%	660,551	Jun 30, 2024
HIGHTOWER ADVISORS, LLC	0.03%	0.00%	76,203	76,203	100.00%	611,000	Jun 30, 2024
WEALTHSPIRE ADVISORS, LLC	0.02%	0.01%	57,000	57,000	100.00%	457,140	Jun 30, 2024
SIT INVESTMENT ASSOCIATES INC	0.02%	0.01%	53,275	53,275	100.00%	427,000	Jun 30, 2024
KETTLE HILL CAPITAL MANAGEMENT, LLC	0.02%	0.08%	41,906	41,906	100.00%	336,086	Jun 30, 2024
OMERS ADMINISTRATION CORP	0.01%	0.00%	33,400	33,400	100.00%	267,868	Jun 30, 2024
JANNEY MONTGOMERY SCOTT LLC	0.01%	0.00%	32,947	32,947	100.00%	264,000	Jun 30, 2024
LOS ANGELES CAPITAL MANAGEMENT LLC	0.01%	0.00%	24,124	24,124	100.00%	193,474	Jun 30, 2024
ENTROPY TECHNOLOGIES, LP	0.01%	0.02%	23,767	23,767	100.00%	190,611	Jun 30, 2024
SEACREST WEALTH MANAGEMENT, LLC	0.01%	0.02%	21,683	21,683	100.00%	173,898	Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.	0.01%	0.00%	18,770	18,770	100.00%	150,535	Jun 30, 2024
WALLEYE CAPITAL LLC	0.01%	0.00%	17,330	17,330	100.00%	138,987	Jun 30, 2024
HEADLANDS TECHNOLOGIES LLC	0.01%	0.01%	16,067	16,067	100.00%	128,857	Jun 30, 2024
BLUESHIFT ASSET MANAGEMENT, LLC	0.01%	0.04%	15,831	15,831	100.00%	126,965	Jun 30, 2024
BEACON FINANCIAL ADVISORY LLC	0.01%	0.04%	14,800	14,800	100.00%	118,696	Jun 30, 2024
CHOREO, LLC	0.01%	0.00%	14,354	14,354	100.00%	115,693	Jun 30, 2024
VONTOBEL HOLDING LTD.	0.01%	0.00%	14,293	14,293	100.00%	114,630	Jun 30, 2024
ALPINE GLOBAL MANAGEMENT, LLC	0.01%	0.02%	14,106	14,106	100.00%	113,130	Jun 30, 2024
BROOKSTONE CAPITAL MANAGEMENT	0.01%	0.00%	13,935	13,935	100.00%	124,579	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	0.00%	0.00%	11,483	11,483	100.00%	92,094	Jun 30, 2024
AVANTAX ADVISORY SERVICES, INC.	0.00%	0.00%	11,409	11,409	100.00%	91,500	Jun 30, 2024
BOLLARD GROUP LLC	0.00%	0.00%	10,700	10,700	100.00%	86,000	Jun 30, 2024
ABACUS PLANNING GROUP, INC.	0.00%	0.02%	10,284	10,284	100.00%	82,478	Jun 30, 2024
ETHIC INC.	0.00%	0.00%	10,242	10,242	100.00%	82,141	Jun 30, 2024
NEUBERGER BERMAN GROUP LLC	0.00%	0.00%	10,034	10,034	100.00%	80,473	Jun 30, 2024
PRIME CAPITAL INVESTMENT ADVISORS, LLC	0.00%	0.00%	10,021	10,021	100.00%	80,368	Jun 30, 2024
CI INVESTMENTS INC.	0.00%	0.00%	7,229	7,229	100.00%	58,000	Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC	0.00%	0.00%	6,609	6,609	100.00%	57,697	Jun 30, 2024
ORG PARTNERS LLC	0.00%	0.00%	3,974	3,974	100.00%	32,030,000	Jun 30, 2024
FLPUTNAM INVESTMENT MANAGEMENT CO	0.00%	0.00%	2,900	2,900	100.00%	23,258	Jun 30, 2024
NBC SECURITIES, INC.	0.00%	0.00%	2,000	2,000	100.00%	16,000	Jun 30, 2024
ITAU UNIBANCO HOLDING S.A.	0.00%	0.00%	1,915	1,915	100.00%	15,358	Jun 30, 2024
OPTIVER HOLDING B.V.	0.00%	-	1,777	1,777	100.00%	14,252	Jun 30, 2024
CAPITAL ADVISORS, LTD. LLC	0.00%	0.00%	885	885	100.00%	7,000	Jun 30, 2024
ASHTON THOMAS PRIVATE WEALTH, LLC	0.00%	0.00%	850	850	100.00%	6,817	Jun 30, 2024
IBEX WEALTH ADVISORS	0.00%	0.00%	500	500	100.00%	4,010	Jun 30, 2024
RIDGEWOOD INVESTMENTS LLC	0.00%	0.00%	300	300	100.00%	2,406	Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP	0.00%	-	181	181	100.00%	1,452	Jun 30, 2024
MATHER GROUP, LLC.	-	-	133	133	100.00%	1,971	Jun 30, 2024
HOBBS GROUP ADVISORS, LLC	-	0.00%	132	132	100.00%	1,059	Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC	-	0.00%	100	100	100.00%	802	Jun 30, 2024
INNEALTA CAPITAL, LLC	-	0.00%	80	80	100.00%	642	Jun 30, 2024
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC	-	0.00%	72	72	100.00%	577	Jun 30, 2024
BELL INVESTMENT ADVISORS, INC	-	0.00%	43	43	100.00%	345	Jun 30, 2024
RONALD BLUE TRUST, INC.	-	-	42	42	100.00%	622	Jun 30, 2024
PLANNING CAPITAL MANAGEMENT CORP	-	0.00%	25	25	100.00%	201	Jun 30, 2024

Iovance Biotherapeutics's largest new institutional shareholder by number of shares is MARSHALL WACE, LLP, purchased 1.61M shares, valued at $12.93M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WOODLINE PARTNERS LP	-	-	-	-1,482,859	-100.00%	-	Jun 30, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC	-	-	-	-642,761	-100.00%	-	Jun 30, 2024
NOMURA ASSET MANAGEMENT CO LTD	-	-	-	-278,135	-100.00%	-	Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC	-	-	-	-244,447	-100.00%	-	Jun 30, 2024
MOODY ALDRICH PARTNERS LLC	-	-	-	-224,831	-100.00%	-	Jun 30, 2024
EAM INVESTORS, LLC	-	-	-	-213,336	-100.00%	-	Jun 30, 2024
FRED ALGER MANAGEMENT, LLC	-	-	-	-182,765	-100.00%	-	Jun 30, 2024
STATE OF NEW JERSEY COMMON PENSION FUND D	-	-	-	-167,959	-100.00%	-	Jun 30, 2024
TREXQUANT INVESTMENT LP	-	-	-	-140,325	-100.00%	-	Jun 30, 2024
MACQUARIE GROUP LTD	-	-	-	-122,053	-100.00%	-	Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.	-	-	-	-116,951	-100.00%	-	Jun 30, 2024
CI PRIVATE WEALTH, LLC	-	-	-	-112,262	-100.00%	-	Jun 30, 2024
HARBOR CAPITAL ADVISORS, INC.	-	-	-	-90,267	-100.00%	-	Jun 30, 2024
D. E. SHAW & CO., INC.	-	-	-	-84,200	-100.00%	-	Jun 30, 2024
HUSSMAN STRATEGIC ADVISORS, INC.	-	-	-	-84,000	-100.00%	-	Jun 30, 2024
MAN GROUP PLC	-	-	-	-80,583	-100.00%	-	Jun 30, 2024
GSA CAPITAL PARTNERS LLP	-	-	-	-61,225	-100.00%	-	Jun 30, 2024
UBS OCONNOR LLC	-	-	-	-40,000	-100.00%	-	Jun 30, 2024
NOMURA HOLDINGS INC	-	-	-	-34,000	-100.00%	-	Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-29,600	-100.00%	-	Jun 30, 2024
GTS SECURITIES LLC	-	-	-	-29,005	-100.00%	-	Jun 30, 2024
J. GOLDMAN & CO LP	-	-	-	-27,000	-100.00%	-	Jun 30, 2024
WALLEYE TRADING LLC	-	-	-	-25,500	-100.00%	-	Jun 30, 2024
GLENMEDE TRUST CO NA	-	-	-	-25,233	-100.00%	-	Jun 30, 2024
HSBC HOLDINGS PLC	-	-	-	-24,644	-100.00%	-	Jun 30, 2024
AQUATIC CAPITAL MANAGEMENT LLC	-	-	-	-21,900	-100.00%	-	Jun 30, 2024
ALLIANZ ASSET MANAGEMENT GMBH	-	-	-	-20,800	-100.00%	-	Jun 30, 2024
TWINBEECH CAPITAL LP	-	-	-	-20,077	-100.00%	-	Jun 30, 2024
AIGEN INVESTMENT MANAGEMENT, LP	-	-	-	-18,510	-100.00%	-	Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD	-	-	-	-16,250	-100.00%	-	Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY	-	-	-	-12,474	-100.00%	-	Jun 30, 2024
SCIENTECH RESEARCH LLC	-	-	-	-11,106	-100.00%	-	Jun 30, 2024
CENTIVA CAPITAL, LP	-	-	-	-11,030	-100.00%	-	Jun 30, 2024
J.W. COLE ADVISORS, INC.	-	-	-	-10,577	-100.00%	-	Jun 30, 2024
ORION PORTFOLIO SOLUTIONS, LLC	-	-	-	-10,250	-100.00%	-	Jun 30, 2024
TORNO CAPITAL, LLC	-	-	-	-10,000	-100.00%	-	Jun 30, 2024
FIDELIS CAPITAL PARTNERS, LLC	-	-	-	-5,903	-100.00%	-	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	-	-	-	-5,100	-100.00%	-	Jun 30, 2024
HARVEST FUND MANAGEMENT CO., LTD	-	-	-	-4,208	-100.00%	-	Jun 30, 2024
BELVEDERE TRADING LLC	-	-	-	-1,000	-100.00%	-	Jun 30, 2024
LARSON FINANCIAL GROUP LLC	-	-	-	-1,000	-100.00%	-	Jun 30, 2024
FIRST MANHATTAN CO. LLC.	-	-	-	-550	-100.00%	-	Jun 30, 2024
FERNWOOD INVESTMENT MANAGEMENT, LLC	-	-	-	-400	-100.00%	-	Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A	-	-	-	-250	-100.00%	-	Jun 30, 2024
MEEDER ASSET MANAGEMENT INC	-	-	-	-88	-100.00%	-	Jun 30, 2024
SOUND INCOME STRATEGIES, LLC	-	-	-	-50	-100.00%	-	Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC	-	-	-	-46	-100.00%	-	Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC	-	-	-	-35	-100.00%	-	Jun 30, 2024

Iovance Biotherapeutics's largest sold out institutional shareholder by shares sold is WOODLINE PARTNERS LP, sold -1.48M shares, valued at -, as of undefined.

Iovance Biotherapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
Manager Directed Portfolios	6.07%	994,366	-	-	Jan 31, 2024
LORD ABBETT DEVELOPING GROWTH FUND, INC.	1.04%	962,053	-	-	Jan 31, 2024
T. Rowe Price Health Sciences Fund, Inc.	0.85%	2,824,997	1,335,315	89.64%	Mar 31, 2024
HARTFORD HLS SERIES FUND II INC	0.53%	131,317	-	-	Dec 31, 2023
TOCQUEVILLE TRUST	0.36%	50,000	-	-	Jan 31, 2024
T. Rowe Price Quantitative Management Funds, Inc.	0.36%	1,139,716	230,958	25.41%	Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS	0.29%	153,847	-	-	Mar 31, 2024
ALGER INSTITUTIONAL FUNDS	0.28%	72,204	72,204	-	Jan 31, 2024
TEKLA HEALTHCARE INVESTORS	0.27%	228,077	-	-	Mar 31, 2024
TEKLA LIFE SCIENCES INVESTORS	0.26%	125,094	-	-	Mar 31, 2024
WANGER ADVISORS TRUST	0.23%	124,109	-	-	Mar 31, 2024
T. Rowe Price New Horizons Fund, Inc.	0.22%	1,117,328	-	-	Mar 31, 2024
COLUMBIA ACORN TRUST	0.21%	691,125	-	-	Mar 31, 2024
ALGER FUNDS	0.19%	186,787	168,238	906.99%	Jan 31, 2024
EntrepreneurShares Series Trust	0.15%	40,887	-	-	Dec 31, 2023
RMB INVESTORS TRUST	0.13%	69,567	3,500	5.30%	Dec 31, 2023
CORNERCAP GROUP OF FUNDS /VA/	0.12%	8,987	3,728	70.89%	Sep 30, 2022
BlackRock Health Sciences Trust	0.12%	30,673	-	-	Mar 31, 2024
PRUDENTIAL SECTOR FUNDS, INC.	0.12%	247,334	-	-	Feb 29, 2024
Voya VARIABLE PRODUCTS TRUST	0.11%	41,010	-	-	Mar 31, 2024
T. Rowe Price Small-Cap Value Fund, Inc.	0.11%	858,100	858,100	-	Mar 31, 2024
Absolute Shares Trust	0.09%	36,566	-	-	Mar 31, 2024
FRANKLIN STRATEGIC SERIES	0.09%	738,792	-	-	Jan 31, 2024
T. Rowe Price Equity Series, Inc.	0.08%	135,669	65,045	92.10%	Mar 31, 2024
M FUND INC	0.08%	37,683	-	-	Mar 31, 2024
LORD ABBETT RESEARCH FUND INC	0.08%	77,210	-	-	Feb 29, 2024
PRUDENTIAL JENNISON BLEND FUND, INC.	0.08%	48,044	48,044	-	Feb 29, 2024
Vericimetry Funds	0.07%	6,622	-	-	Mar 31, 2024
Humankind Benefit Corp	0.07%	1,562	-	-	Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC	0.07%	415,923	-1,821	-0.44%	Mar 31, 2024
BlackRock Health Sciences Trust II	0.06%	168,215	-	-	Mar 31, 2024
VICTORY VARIABLE INSURANCE FUNDS	0.06%	31,584	-	-	Mar 31, 2024
Nuveen NASDAQ 100 Dynamic Overwrite Fund	0.06%	7,172	-	-	Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.06%	35,226	41	0.12%	Mar 31, 2024
FIDELITY ADVISOR SERIES VII	0.05%	451,900	-	-	Jan 31, 2024
VANGUARD INDEX FUNDS	0.05%	22,251,098	-1,212,746	-5.17%	Mar 31, 2024
T. Rowe Price Small-Cap Stock Fund, Inc.	0.04%	151,586	-	-	Mar 31, 2024
NEUBERGER BERMAN ADVISERS MANAGEMENT TRUST	0.04%	71,400	-	-	Mar 31, 2024
Tekla Healthcare Opportunities Fund	0.03%	77,000	-	-	Mar 31, 2024
NEUBERGER BERMAN EQUITY FUNDS	0.03%	325,000	-	-	Feb 29, 2024
Tekla World Healthcare Fund	0.03%	38,367	-	-	Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 1	0.03%	7,077	2,630	59.14%	Mar 31, 2024
FIDELITY COMMONWEALTH TRUST	0.03%	99,327	1,612	1.65%	Feb 29, 2024
Voya EQUITY TRUST	0.03%	41,552	-	-	Feb 29, 2024
Calvert Responsible Index Series, Inc.	0.03%	45,307	-	-	Mar 31, 2024
ALGER PORTFOLIOS	0.02%	9,306	-	-	Dec 31, 2023
LKCM Funds	0.02%	93,550	-	-	Mar 31, 2024
IndexIQ ETF Trust	0.02%	53,249	-3,724	-6.54%	Jan 31, 2024
HARTFORD SERIES FUND INC	0.02%	992,143	-	-	Mar 31, 2024
RYDEX SERIES FUNDS	0.02%	97,553	95,655	5039.78%	Dec 31, 2023
AIM GROWTH SERIES (INVESCO GROWTH SERIES)	0.02%	688,821	-	-	Mar 31, 2024
AB CAP FUND, INC.	0.02%	724,788	-	-	Jan 31, 2024
BNY Mellon Strategic Funds, Inc.	0.02%	43,488	-10,765	-19.84%	Feb 29, 2024
Nushares ETF Trust	0.02%	128,946	-	-	Jan 31, 2024
DRIEHAUS MUTUAL FUNDS	0.02%	135,303	135,303	-	Mar 28, 2024
SCHWAB CAPITAL TRUST	0.01%	626,555	-4,503	-0.71%	Jan 31, 2024
ETF Managers Trust	0.01%	114,431	-	-	Dec 31, 2023
AMERICAN CENTURY MUTUAL FUNDS, INC.	0.01%	138,333	-	-	Jan 31, 2024
JNL VARIABLE FUND LLC	0.01%	75,884	-5,662	-6.94%	Mar 31, 2020
FORUM FUNDS	0.01%	30,445	-	-	Jan 31, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.	0.01%	26,906	26,592	8468.79%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.01%	2,287,667	323,127	16.45%	Feb 29, 2024
Gabelli Healthcare & WellnessRx Trust	0.01%	1,216	-	-	Dec 29, 2023
RYDEX VARIABLE TRUST	0.01%	10,519	10,395	8383.06%	Dec 31, 2023
Calvert Variable Products, Inc.	0.01%	22,989	-	-	Mar 31, 2024
ALPS ETF Trust	0.01%	99,737	-	-	Feb 29, 2024
Direxion Shares ETF Trust	0.01%	1,197,767	22,848	1.94%	Jan 31, 2024
T. Rowe Price Equity Funds, Inc.	0.01%	84,400	-	-	Mar 31, 2024
ETFis Series Trust I	0.01%	10,644	-761	-6.67%	Jan 31, 2024
FIDELITY SELECT PORTFOLIOS	0.01%	458,700	-	-	Feb 29, 2024
Brown Advisory Funds	0.01%	250,891	-	-	Mar 31, 2024
CLEARWATER INVESTMENT TRUST	0.01%	63,999	-	-	Mar 28, 2024
John Hancock Exchange-Traded Fund Trust	0.01%	40,495	-	-	Jan 31, 2024
NORTHWESTERN MUTUAL SERIES FUND INC	0.01%	691,453	-	-	Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS	0.01%	29,300	-	-	Mar 31, 2024
Virtus Investment Trust	0.01%	202,449	-589	-0.29%	Mar 28, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.01%	156,148	-3,470	-2.17%	Mar 31, 2024
North Square Investments Trust	0.01%	48,740	-	-	Jan 31, 2024
AMG Funds IV	0.00%	14,472	-	-	Jan 31, 2024
Bernstein Fund Inc	0.00%	40,308	-	-	Mar 31, 2024
Harbor ETF Trust	0.00%	20,927	-1,839	-8.08%	Jan 31, 2024
Ark ETF Trust	0.00%	34,852	-	-	Jan 31, 2024
UBS FUNDS	0.00%	20,721	-	-	Mar 31, 2024
Federated Hermes Equity Funds	0.00%	78,054	-	-	Jan 31, 2024
DEUTSCHE DWS INVESTMENT TRUST	0.00%	11,302	-	-	Jan 31, 2024
VANGUARD WHITEHALL FUNDS	0.00%	328,290	-	-	Jan 31, 2024
FIDELITY SECURITIES FUND	0.00%	322,000	-	-	Jan 31, 2024
TIAA-CREF LIFE FUNDS	0.00%	9,297	-1,601	-14.69%	Mar 31, 2024
VANGUARD WORLD FUND	0.00%	809,072	9,445	1.18%	Feb 29, 2024
INVESCO EXCHANGE-TRADED FUND TRUST	0.00%	264,993	189,821	252.52%	Jan 31, 2024
PFM Multi-Manager Series Trust	0.00%	2,600	-	-	Dec 31, 2023
AB VARIABLE PRODUCTS SERIES FUND, INC.	0.00%	14,084	-	-	Mar 31, 2024
VANGUARD EXPLORER FUND	0.00%	36,960	-	-	Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	35,700	14,126	65.48%	Mar 31, 2024
OPTIMUM FUND TRUST	0.00%	122,901	67,066	120.11%	Mar 28, 2024
FIDELITY MT VERNON STREET TRUST	0.00%	78,092	-	-	Feb 29, 2024
ProFunds	0.00%	31,497	-40,359	-56.17%	Mar 31, 2024
ALLSPRING MASTER TRUST	0.00%	175,630	-	-	Feb 29, 2024
SSGA FUNDS	0.00%	1,144	-	-	Feb 29, 2024
NUVEEN INVESTMENT FUNDS INC	0.00%	87,353	-	-	Jan 31, 2024

Iovance Biotherapeutics's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 994.37K shares, compromising 6.07% of its total assets.

Iovance Biotherapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	121	-59.26%
31 Mar, 24	297	18.33%
31 Dec, 23	251	1.21%
30 Sep, 23	248	8.30%
30 Jun, 23	229	-3.38%
31 Mar, 23	237	5.33%
31 Dec, 22	225	-8.16%
30 Sep, 22	245	-1.61%
30 Jun, 22	249	-4.60%
31 Mar, 22	261	-0.76%
31 Dec, 21	263	-1.50%
30 Sep, 21	267	3.49%
30 Jun, 21	258	-3.37%
31 Mar, 21	267	-6.64%
31 Dec, 20	286	8.33%
30 Sep, 20	264	-2.94%
30 Jun, 20	272	11.48%
31 Mar, 20	244	12.96%
31 Dec, 19	216	22.03%
30 Sep, 19	177	1.14%
30 Jun, 19	175	14.38%
31 Mar, 19	153	9.29%
31 Dec, 18	140	3.70%
30 Sep, 18	135	2.27%
30 Jun, 18	132	0.76%
31 Mar, 18	131	37.89%
31 Dec, 17	95	3.26%
30 Sep, 17	92	4.55%
30 Jun, 17	88	-

As of 30 Jun 24, 121 institutions are holding Iovance Biotherapeutics's shares, representing a decrease of -59.26% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	24,165,509	-88.82%
31 Mar, 24	216,063,214	4.25%
31 Dec, 23	207,248,234	-2.24%
30 Sep, 23	212,001,334	4.53%
30 Jun, 23	202,805,590	-1.26%
31 Mar, 23	205,391,698	18.51%
31 Dec, 22	173,305,108	12.39%
30 Sep, 22	154,192,925	-3.23%
30 Jun, 22	159,347,112	2.19%
31 Mar, 22	155,933,270	0.07%
31 Dec, 21	155,825,805	-1.32%
30 Sep, 21	157,905,754	-2.56%
30 Jun, 21	162,053,478	3.24%
31 Mar, 21	156,974,341	5.63%
31 Dec, 20	148,612,072	6.27%
30 Sep, 20	139,841,814	-0.60%
30 Jun, 20	140,691,678	14.83%
31 Mar, 20	122,524,063	-1.28%
31 Dec, 19	124,116,769	0.57%
30 Sep, 19	123,408,596	0.82%
30 Jun, 19	122,410,141	4.32%
31 Mar, 19	117,339,926	-1.02%
31 Dec, 18	118,554,358	31.02%
30 Sep, 18	90,487,038	8.70%
30 Jun, 18	83,242,464	7.08%
31 Mar, 18	77,740,619	34.87%
31 Dec, 17	57,639,750	4.23%
30 Sep, 17	55,299,732	16.09%
30 Jun, 17	47,635,722	-

Iovance Biotherapeutics (IOVA) has 24.17M shares outstanding as of 30 Jun 24, down -88.82% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	9.08%	0.13%
31 Mar, 24	84.42%	1.19%
31 Dec, 23	84.31%	0.95%
30 Sep, 23	94.44%	1.05%
30 Jun, 23	94.90%	1.03%
31 Mar, 23	96.11%	0.87%
31 Dec, 22	105.18%	1.10%
30 Sep, 22	97.70%	0.95%
30 Jun, 22	101.32%	1.03%
31 Mar, 22	99.25%	1.01%
31 Dec, 21	99.30%	0.96%
30 Sep, 21	101.54%	0.91%
30 Jun, 21	105.40%	0.93%
31 Mar, 21	106.52%	0.92%
31 Dec, 20	107.46%	1.18%
30 Sep, 20	95.46%	0.86%
30 Jun, 20	105.65%	1.13%
31 Mar, 20	96.80%	0.97%
31 Dec, 19	99.82%	1.01%
30 Sep, 19	99.50%	1.01%
30 Jun, 19	99.06%	1.10%
31 Mar, 19	95.08%	0.96%
31 Dec, 18	99.55%	1.10%
30 Sep, 18	95.17%	1.12%
30 Jun, 18	92.25%	1.09%
31 Mar, 18	92.16%	1.18%
31 Dec, 17	88.35%	1.16%
30 Sep, 17	87.32%	1.50%
30 Jun, 17	76.27%	-

As of 30 Jun 24, Iovance Biotherapeutics is held by 9.08% institutional shareholders, representing a 0.13% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	73	-54.66%
31 Mar, 24	161	13.38%
31 Dec, 23	142	-2.74%
30 Sep, 23	146	18.70%
30 Jun, 23	123	-1.60%
31 Mar, 23	125	10.62%
31 Dec, 22	113	0.89%
30 Sep, 22	112	-23.29%
30 Jun, 22	146	-5.81%
31 Mar, 22	155	20.16%
31 Dec, 21	129	0.78%
30 Sep, 21	128	-11.72%
30 Jun, 21	145	5.84%
31 Mar, 21	137	-8.67%
31 Dec, 20	150	19.05%
30 Sep, 20	126	-24.55%
30 Jun, 20	167	32.54%
31 Mar, 20	126	4.13%
31 Dec, 19	121	32.97%
30 Sep, 19	91	-10.78%
30 Jun, 19	102	45.71%
31 Mar, 19	70	-27.84%
31 Dec, 18	97	29.33%
30 Sep, 18	75	-1.32%
30 Jun, 18	76	-20.83%
31 Mar, 18	96	92.00%
31 Dec, 17	50	-3.85%
30 Sep, 17	52	-37.35%
30 Jun, 17	83	-

73 institutional shareholders have increased their position in IOVA stock as of 30 Jun 24 compared to 161 in the previous quarter (a -54.66% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	32	-63.64%
31 Mar, 24	88	31.34%
31 Dec, 23	67	21.82%
30 Sep, 23	55	-14.06%
30 Jun, 23	64	-3.03%
31 Mar, 23	66	-4.35%
31 Dec, 22	69	-19.77%
30 Sep, 22	86	28.36%
30 Jun, 22	67	3.08%
31 Mar, 22	65	-23.53%
31 Dec, 21	85	1.19%
30 Sep, 21	84	44.83%
30 Jun, 21	58	-28.40%
31 Mar, 21	81	-17.35%
31 Dec, 20	98	3.16%
30 Sep, 20	95	35.71%
30 Jun, 20	70	-5.41%
31 Mar, 20	74	15.63%
31 Dec, 19	64	16.36%
30 Sep, 19	55	34.15%
30 Jun, 19	41	-14.58%
31 Mar, 19	48	60.00%
31 Dec, 18	30	3.45%
30 Sep, 18	29	-17.14%
30 Jun, 18	35	84.21%
31 Mar, 18	19	-13.64%
31 Dec, 17	22	10.00%
30 Sep, 17	20	-
30 Jun, 17	-	-

32 institutional shareholders have reduced their position in IOVA stock as of 30 Jun 24 compared to 88 in the previous quarter (a -63.64% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	121	-59.26%	24,165,509	-88.82%	9.08%	0.13%	73	-54.66%	32	-63.64%
31 Mar, 24	297	18.33%	216,063,214	4.25%	84.42%	1.19%	161	13.38%	88	31.34%
31 Dec, 23	251	1.21%	207,248,234	-2.24%	84.31%	0.95%	142	-2.74%	67	21.82%
30 Sep, 23	248	8.30%	212,001,334	4.53%	94.44%	1.05%	146	18.70%	55	-14.06%
30 Jun, 23	229	-3.38%	202,805,590	-1.26%	94.90%	1.03%	123	-1.60%	64	-3.03%
31 Mar, 23	237	5.33%	205,391,698	18.51%	96.11%	0.87%	125	10.62%	66	-4.35%
31 Dec, 22	225	-8.16%	173,305,108	12.39%	105.18%	1.10%	113	0.89%	69	-19.77%
30 Sep, 22	245	-1.61%	154,192,925	-3.23%	97.70%	0.95%	112	-23.29%	86	28.36%
30 Jun, 22	249	-4.60%	159,347,112	2.19%	101.32%	1.03%	146	-5.81%	67	3.08%
31 Mar, 22	261	-0.76%	155,933,270	0.07%	99.25%	1.01%	155	20.16%	65	-23.53%
31 Dec, 21	263	-1.50%	155,825,805	-1.32%	99.30%	0.96%	129	0.78%	85	1.19%
30 Sep, 21	267	3.49%	157,905,754	-2.56%	101.54%	0.91%	128	-11.72%	84	44.83%
30 Jun, 21	258	-3.37%	162,053,478	3.24%	105.40%	0.93%	145	5.84%	58	-28.40%
31 Mar, 21	267	-6.64%	156,974,341	5.63%	106.52%	0.92%	137	-8.67%	81	-17.35%
31 Dec, 20	286	8.33%	148,612,072	6.27%	107.46%	1.18%	150	19.05%	98	3.16%
30 Sep, 20	264	-2.94%	139,841,814	-0.60%	95.46%	0.86%	126	-24.55%	95	35.71%
30 Jun, 20	272	11.48%	140,691,678	14.83%	105.65%	1.13%	167	32.54%	70	-5.41%
31 Mar, 20	244	12.96%	122,524,063	-1.28%	96.80%	0.97%	126	4.13%	74	15.63%
31 Dec, 19	216	22.03%	124,116,769	0.57%	99.82%	1.01%	121	32.97%	64	16.36%
30 Sep, 19	177	1.14%	123,408,596	0.82%	99.50%	1.01%	91	-10.78%	55	34.15%
30 Jun, 19	175	14.38%	122,410,141	4.32%	99.06%	1.10%	102	45.71%	41	-14.58%
31 Mar, 19	153	9.29%	117,339,926	-1.02%	95.08%	0.96%	70	-27.84%	48	60.00%
31 Dec, 18	140	3.70%	118,554,358	31.02%	99.55%	1.10%	97	29.33%	30	3.45%
30 Sep, 18	135	2.27%	90,487,038	8.70%	95.17%	1.12%	75	-1.32%	29	-17.14%
30 Jun, 18	132	0.76%	83,242,464	7.08%	92.25%	1.09%	76	-20.83%	35	84.21%
31 Mar, 18	131	37.89%	77,740,619	34.87%	92.16%	1.18%	96	92.00%	19	-13.64%
31 Dec, 17	95	3.26%	57,639,750	4.23%	88.35%	1.16%	50	-3.85%	22	10.00%
30 Sep, 17	92	4.55%	55,299,732	16.09%	87.32%	1.50%	52	-37.35%	20	-
30 Jun, 17	88	-	47,635,722	-	76.27%	-	83	-	-	-

Iovance Biotherapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 17, 2024	Vogt Frederick G	officer	Interim CEO & General Counsel	F-InKind	Sell	8,851	$8.68	$76.83K	159,309
Jul 17, 2024	Vogt Frederick G	officer	Interim CEO & General Counsel	M-Exempt	Sell	20,835	-	-	41,669
Jul 17, 2024	GRAF FINCKENSTEIN FRIEDRICH	officer	Chief Medical Officer	F-InKind	Sell	1,428	$8.68	$12.40K	45,871
Jul 17, 2024	GRAF FINCKENSTEIN FRIEDRICH	officer	Chief Medical Officer	M-Exempt	Sell	2,813	-	-	5,626
Jul 17, 2024	BILINSKY IGOR	officer	Chief Operating Officer	F-InKind	Sell	1,428	$8.68	$12.40K	41,143
Jul 17, 2024	BILINSKY IGOR	officer	Chief Operating Officer	M-Exempt	Sell	2,813	-	-	5,626
Jun 05, 2024	GRAF FINCKENSTEIN FRIEDRICH	officer	Chief Medical Officer	F-InKind	Sell	1,982	$8.37	$16.59K	44,486
Jun 05, 2024	GRAF FINCKENSTEIN FRIEDRICH	officer	Chief Medical Officer	M-Exempt	Sell	3,906	-	-	27,346
Jun 05, 2024	BILINSKY IGOR	officer	Chief Operating Officer	F-InKind	Sell	1,784	$8.37	$14.93K	39,758
Jun 05, 2024	BILINSKY IGOR	officer	Chief Operating Officer	M-Exempt	Sell	3,516	-	-	24,613

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 17, 2024	Vogt Frederick G	officer	Interim CEO & General Counsel	M-Exempt	Buy	20,835	-	-	168,160
Jul 17, 2024	Vogt Frederick G	officer	Interim CEO & General Counsel	F-InKind	Sell	8,851	$8.68	$76.83K	159,309
Jul 17, 2024	Vogt Frederick G	officer	Interim CEO & General Counsel	M-Exempt	Sell	20,835	-	-	41,669
Jul 17, 2024	GRAF FINCKENSTEIN FRIEDRICH	officer	Chief Medical Officer	M-Exempt	Buy	2,813	-	-	47,299
Jul 17, 2024	GRAF FINCKENSTEIN FRIEDRICH	officer	Chief Medical Officer	F-InKind	Sell	1,428	$8.68	$12.40K	45,871
Jul 17, 2024	GRAF FINCKENSTEIN FRIEDRICH	officer	Chief Medical Officer	M-Exempt	Sell	2,813	-	-	5,626
Jul 17, 2024	BILINSKY IGOR	officer	Chief Operating Officer	M-Exempt	Buy	2,813	-	-	42,571
Jul 17, 2024	BILINSKY IGOR	officer	Chief Operating Officer	F-InKind	Sell	1,428	$8.68	$12.40K	41,143
Jul 17, 2024	BILINSKY IGOR	officer	Chief Operating Officer	M-Exempt	Sell	2,813	-	-	5,626
Jun 13, 2024	Countouriotis Athena	director	-	A-Award	Buy	49,303	-	-	49,303
Jun 13, 2024	YARNO WENDY L	director	-	A-Award	Buy	49,303	-	-	49,303
Jun 13, 2024	WEISER MICHAEL	director	-	A-Award	Buy	49,303	-	-	49,303
Jun 13, 2024	Maynard Ryan D	director	-	A-Award	Buy	49,303	-	-	49,303
Jun 13, 2024	Dukes Iain D.	director	-	A-Award	Buy	98,607	-	-	98,607
Jun 05, 2024	GRAF FINCKENSTEIN FRIEDRICH	officer	Chief Medical Officer	M-Exempt	Buy	3,906	-	-	46,468
Jun 05, 2024	GRAF FINCKENSTEIN FRIEDRICH	officer	Chief Medical Officer	F-InKind	Sell	1,982	$8.37	$16.59K	44,486
Jun 05, 2024	GRAF FINCKENSTEIN FRIEDRICH	officer	Chief Medical Officer	M-Exempt	Sell	3,906	-	-	27,346
Jun 05, 2024	BILINSKY IGOR	officer	Chief Operating Officer	M-Exempt	Buy	3,516	-	-	41,542
Jun 05, 2024	BILINSKY IGOR	officer	Chief Operating Officer	F-InKind	Sell	1,784	$8.37	$14.93K	39,758
Jun 05, 2024	BILINSKY IGOR	officer	Chief Operating Officer	M-Exempt	Sell	3,516	-	-	24,613

The last insider sell of Iovance Biotherapeutics's stock was made by Vogt Frederick G on Jul 17 2024, selling 8,851 shares at $8.68 per share (valued at $76.83K).

Iovance Biotherapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	3	6	50.00%
Q2 2024	11	12	91.67%
Q1 2024	24	12	200.00%
Q4 2023	3	6	50.00%
Q3 2023	5	6	83.33%
Q2 2023	10	6	166.67%
Q1 2023	13	12	108.33%
Q4 2022	6	-	-
Q3 2022	2	-	-
Q2 2022	20	3	666.67%
Q1 2022	6	-	-
Q4 2021	-	-	-
Q2 2021	10	-	-
Q1 2021	5	-	-
Q4 2020	1	-	-
Q2 2020	5	6	83.33%
Q1 2020	3	3	100.00%
Q4 2019	-	3	-
Q3 2019	1	3	33.33%
Q2 2019	5	3	166.67%

3 total buy trades, and 6 total sell trades (buy/sell ratio of 0.50%) were made by Iovance Biotherapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	-	-
Q2 2024	-	-	-
Q1 2024	3	-	-
Q4 2023	-	-	-
Q3 2023	2	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	6	-	-
Q3 2022	-	-	-
Q2 2022	8	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q4 2020	-	-	-
Q2 2020	-	-	-
Q1 2020	-	-	-
Q4 2019	-	-	-
Q3 2019	-	-	-
Q2 2019	-	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Iovance Biotherapeutics's stocks.

Iovance Biotherapeutics Peer Ownership

Ticker	Company
PTCT	PTC Therapeutics, Inc.
CWBR	CohBar, Inc.
APLS	Apellis Pharmaceuticals, Inc.
CVAC	CureVac N.V.
SRPT	Sarepta Therapeutics, Inc.
KRYS	Krystal Biotech, Inc.
OCEA	Ocean Biomedical, Inc.
HEPA	Hepion Pharmaceuticals, Inc.
MDGL	Madrigal Pharmaceuticals, Inc.

IOVA Ownership FAQ

Who Owns Iovance Biotherapeutics?

Iovance Biotherapeutics is owned by institutional shareholders (9.08%), insiders (0.50%), and public (90.42%). The largest institutional shareholder of Iovance Biotherapeutics is VANGUARD GROUP INC (9.75% of total shares) and the top mutual fund owner is Manager Directed Portfolios (6.07% of total shares).

Who are the major institutional shareholders of Iovance Biotherapeutics?

Iovance Biotherapeutics's major institutional shareholders are VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, MHR FUND MANAGEMENT LLC, BLACKROCK INC., and STATE STREET CORP. The top five shareholders own together 41.22% of the company's share outstanding.

How many Iovance Biotherapeutics shareholders are there?

As of Jun 2024, there are 121 institutional shareholders of Iovance Biotherapeutics.

What percentage of Iovance Biotherapeutics is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC owns 25.95M shares of Iovance Biotherapeutics, representing 9.75% of the company's total shares outstanding, valued at $208.12M (as of Jun 2024).

What percentage of Iovance Biotherapeutics is owned by PERCEPTIVE ADVISORS LLC?

As of Jun 2024, PERCEPTIVE ADVISORS LLC holds 25.93M shares of Iovance Biotherapeutics (IOVA), compromising 9.74% of the company, valued at $207.98M.

What percentage of Iovance Biotherapeutics is owned by MHR FUND MANAGEMENT LLC?

MHR FUND MANAGEMENT LLC is the third largest holder of Iovance Biotherapeutics. The company owns 24M of the company's shares outstanding (worth $192.46M).